| abstract |
A pharmaceutical composition for inhibiting abnormal cell growth or for the treatment of a proliferative disease in a mammal, characterized in that it comprises an amount of (2-hydroxy-ethoxy) -amide of 6- (4-bromo-2-chloro-phenylamino acid) ) -7-fluoro-3-methyl-3H-benzoimidazol-5-carboxylic acid, or a pharmaceutically acceptable salt thereof, in combination with an amount of a chemotherapeutic agent or radiation therapy, wherein the amounts of the compound or salt and the Chemotherapeutic agent or radiation therapy are together, effective in inhibiting said abnormal cell growth or said proliferative disease. |